WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Stock

Open Broker Account
$18.75+0.49 (+2.68%)
Updated Sep 27, 2022
VIR Price
$18.75
Fair Value Price
$30.11
Market Cap
$2.49B
52 Week Low
$18.05
52 Week High
$58.00
P/E
2.28x
P/B
1.27x
P/S
1.6x
PEG
0.01x
Dividend Yield
N/A
Revenue
$2.11B
Earnings
$1.08B
Gross Margin
91.3%
Operating Margin
63.79%
Profit Margin
51.1%
Debt to Equity
0.34
Operating Cash Flow
$1B
Beta
0.33
Next Earnings
Nov 2, 2022
Ex-Dividend
N/A
Next Dividend
N/A

VIR Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VIR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VIR ($18.75) is undervalued by 37.74% relative to our estimate of its Fair Value price of $30.11 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
VIR ($18.75) is significantly undervalued by 37.74% relative to our estimate of its Fair Value price of $30.11 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
VIR ($18.75) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VIR due diligence checks available for Premium users.

Be the first to know about important VIR news, forecast changes, insider trades & much more!

VIR News

Valuation

VIR fair value

Fair Value of VIR stock based on Discounted Cash Flow (DCF)
Price
$18.75
Fair Value
$30.11
Undervalued by
37.74%
VIR ($18.75) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VIR ($18.75) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VIR ($18.75) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

VIR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
2.28x
Industry
15.18x
Market
28.09x
VIR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
VIR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

VIR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.27x
Industry
4.3x
VIR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VIR price to earnings growth (PEG)

For valuing profitable companies with growth potential
VIR is good value based... subscribe to Premium to read more.
PEG Value Valuation

VIR's financial health

Profit margin

Revenue
-$40.6M
Net Income
-$76.5M
Profit Margin
188.3%
VIR's Earnings (EBIT) of $1.34B... subscribe to Premium to read more.
Interest Coverage Financials
VIR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.6B
Liabilities
$667.0M
Debt to equity
0.34
VIR's short-term assets ($2.29B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VIR's short-term assets ($2.29B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VIR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$960.1M
Investing
-$272.3M
Financing
$3.1M
VIR's operating cash flow ($1.41B)... subscribe to Premium to read more.
Debt Coverage Financials

VIR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
VIR$2.49B+2.68%2.28x1.27x
HRMY$2.52B+1.40%43.52x10.23x
RLAY$2.54B+5.82%-9.10x3.25x
INSM$2.56B+1.91%-6.09x57.95x
BCRX$2.33B+3.39%-10.89x-10.92x

Vir Biotechnology Stock FAQ

What is Vir Biotechnology's quote symbol?

NASDAQ: VIR) Vir Biotechnology trades on the NASDAQ under the ticker symbol VIR. Vir Biotechnology stock quotes can also be displayed as NASDAQ: VIR.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.

What is the 52 week high and low for Vir Biotechnology (NASDAQ: VIR)?

(NASDAQ: VIR) Vir Biotechnology's 52-week high was $58.00, and its 52-week low was $18.05. It is currently -67.67% from its 52-week high and 3.88% from its 52-week low.

How much is Vir Biotechnology stock worth today?

(NASDAQ: VIR) Vir Biotechnology currently has 132,637,878 outstanding shares. With Vir Biotechnology stock trading at $18.75 per share, the total value of Vir Biotechnology stock (market capitalization) is $2.49B.

Vir Biotechnology stock was originally listed at a price of $14.02 in Oct 11, 2019. If you had invested in Vir Biotechnology stock at $14.02, your return over the last 2 years would have been 33.74%, for an annualized return of 15.64% (not including any dividends or dividend reinvestments).

How much is Vir Biotechnology's stock price per share?

(NASDAQ: VIR) Vir Biotechnology stock price per share is $18.75 today (as of Sep 27, 2022).

What is Vir Biotechnology's Market Cap?

(NASDAQ: VIR) Vir Biotechnology's market cap is $2.49B, as of Sep 28, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vir Biotechnology's market cap is calculated by multiplying VIR's current stock price of $18.75 by VIR's total outstanding shares of 132,637,878.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.